FDA Warns Cosmetics Co. on Possible Seizure, Etc. for FFDCA Marketing Violation
The Food and Drug Administration has issued a warning letter to Refine USA, LLC regarding its marketing of the VeinGogh Ohmic Thermolysis System without marketing clearance or approval, in violation of the Federal Food, Drug, and Cosmetic Act. FDA states…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
that failure to promptly correct the violations may result in regulatory action being initiated, including, but not limited to, seizure, injunction, and/or civil penalties.